MEDICA Newsletter
Social Media
More about…
- 3D printing
- ADHD
- Adiposity
- Age
- Allergy
- Alzheimer's
- Antibiotics
- Arthrosis
- Artificial intelligence
- Asthma
- Autism
- Baby
- Biocompatible
- Biofeedback
- Biomarker
- Biotechnology
- Bladder
- Blood
- Brain
- Breast
- CT
- Cancer
- Cardiovascular
- Care
- Cells
- Children
- Communication
- Dementia
- Depression
- Devices
- Diabetes
- Diagnostics
- Drugs
- EEG
- Electronic/digital patient file
- Emergency Medicine
- Environment
- Epilepsy
- Eyes
- Fitness
- Further education and training
- Genetic Material
- Genetics
- Germany
- Global Health
- Health Care Politics
- Heart
- Hepatitis
- Hospital
- Hygiene
- Hypertension
- Imaging
- Immune System
- Implants
- Infectious Disease
- Information Technology
- Intensive Medicine
- Intestine
- Kidney
- Laboratory
- Laser
- Leukaemia
- Liver
- Lung
- MRI
- MRSA
- Materials
- Media
- Medical Apps
- Medical Markets
- Men
- Microsystems Technology
- Minimal Invasive
- Multiple Sclerosis
- Neurology
- Optical Technologies
- Optimisation
- Organs
- Orthopedics
- Paraplegia
- Parkinson's
- Pathogens
- Pathology
- Patients
- Personalized Medicine
- Physicians
- Polymers
- Pregnancy
- Prevention
- Prostate
- Prosthesis
- Psychology
- Quality
- Regenerative Medicine
- Rehabilitation
- Research
- Risks
- Robotics
- SARS-CoV-2/COVID-19
- Safety
- Screening
- Screening
- Senses
- Skin
- Software
- Sports
- Stem Cells
- Sterilisation
- Stroke
- Surgery
- Surgery
- Telemedicine
- Therapy
- Tissue Engineering
- Transplantation
- Treatment
- USA
- Vaccination
- Virtual Reality
- Wearable technologies
- Women
- Wound Healing
- X-ray devices
Enabling safe delivery of RNA drugs to the lungs
05/08/2021
Hokkaido University researchers in Japan created and tested a library of lipid-based compounds to find a way to safely and effectively deliver RNA drugs to the lungs.
App to help caregivers manage medication for dementia patients
30/07/2021
Most of the six million people in the U.S. who live with Alzheimer's disease and related dementias rely on informal caregivers, usually family or friends, to help manage their medications. Researchers from Regenstrief Institute, Indiana University and University of Wisconsin have received a grant to create an application to support those caregivers.
SARS-CoV-2: rapid method to quantify antibodies
29/07/2021
Scientists have developed a rapid, highly accurate test to detect antibodies against the spike protein of SARS-CoV-2 in human serum, opening a new avenue for understanding the full extent of the pandemic and evaluating the effectiveness of vaccines.
Hollow nano-objects made of DNA could trap viruses
28/07/2021
To date, there are no effective antidotes against most virus infections. An interdisciplinary research team at the Technical University of Munich (TUM) has now developed a new approach: they engulf and neutralize viruses with nano-capsules tailored from genetic material using the DNA origami method.
Breakthrough in detection of SARS-CoV-2 variant in wastewater
27/07/2021
SMART researchers have developed an innovative method to detect and quantify the more transmissible B.1.1.7 (Alpha) variant of concern via wastewater epidemiology.
Low-cost method for finding new coronavirus variants
30/06/2021
Researchers at Karolinska Institutet in Sweden have developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants. The technique is presented in Nature Communications.
Point-of-care tests: rapid diagnosis in emergency situations
01/06/2021
In emergency medicine, a faster diagnosis leads to a faster treatment of the patient. Point-of-care test solutions can provide immediate on-site insights into the patient’s condition. COVID-19 adds another dimension: the devices can provide a level of security and safety – one that goes beyond intensive care.
rhCollagen: genetically engineered building block for regenerative medicine
03/02/2020
Collagen is the stuff that holds our bodies together and that houses our cells. In regenerative medicine, it is also the stuff that can be applied to wounds to support healing. However, collagen from animal or human sources has some drawbacks for today’s medicine. This is where rhCollagen from the Israeli company CollPlant comes into play.
Last-resort antibiotics: "We can identify carbapenemases within half an hour"
01/08/2019
Antibiotic resistance is modern medicine's greatest challenge. Some bacteria only respond to a handful of antibiotics, prompting hospitals to spend a lot of time finding an effective drug. That’s why it is critical for physicians to rapidly identify antibiotic resistance to avoid ineffective treatments.
Personalized medicine: a paradigm shift is gaining momentum
01/03/2018
Personalized medicine does not follow a "one-size-fits-all" treatment approach but emphasizes a "tailor-made" paradigm, meaning a treatment is customized to each individual person's case. For patients, this increases the chances of treatment success and means fewer side effects. While the approach originates in the field of oncology, it is now also increasingly applied to other disease patterns.
On the trail of cancer: personalized cancer vaccine
01/03/2018
Conventional cancer treatment selection typically depends on the location of the tumor. However, this approach ignores the distinct gene mutations in the tumor of the individual patient. New cancer research approaches increasingly emphasize the concept of personalized therapy.
Personalized cancer medicine: customized treatment
01/03/2018
Everyone is different. This statement also applies to our health. Cancer, in particular, can look and progress differently depending on the individual person. That’s why every patient ideally also needs a customized treatment that is tailored to their individual needs. But how feasible is this idea?